What Are The Absolute And Relative Contraindications Clinicians Must Screen For Prior To Operating Fractional Laser Resurfacing Equipment? Key Risks & Safety

Clinicians should treat active infection, recent systemic retinoid use, and inability to follow aftercare as the principal absolute contraindications to fractional laser resurfacing. Before treating, they must also assess photosensitivity, pregnancy or breastfeeding, prior tissue injury, scarring history, wound-healing capacity, and the patient’s ability to follow postoperative instructions. The classification can change with the device, wavelength, treatment depth, and whether the procedure is ablative or non-ablative.

Fractional resurfacing is not automatically low risk. Screen first for conditions that impair re-epithelialization or increase infection, pigmentary, and scarring risks; defer treatment or modify the protocol when those risks can be controlled.

What Must Be Ruled Out Before Treatment

Active infection in the treatment area

Active bacterial, viral, or fungal infection is an absolute contraindication until it has resolved. Treating infected skin can worsen the infection, delay healing, and increase the risk of scarring.

A history of herpes simplex is different from an active outbreak. It generally requires antiviral prophylaxis according to the clinician’s protocol, particularly when ablative resurfacing is planned.

Current or recent oral retinoid therapy

Current isotretinoin or related systemic retinoid use is an absolute contraindication under the primary screening standard. Treatment should also be deferred after recent use, with the relevant interval verified against the device labeling, treatment depth, and local clinical protocol.

The commonly cited interval is at least six months, but some protocols recommend longer delays for deeper or full-field ablative procedures. Fractional ablative and non-ablative treatments may have different risk profiles, so clinicians should not apply a single interval indiscriminately.

Inability to complete wound care

A patient who cannot reliably follow postoperative wound care, infection-prevention measures, or sun-protection requirements should not undergo treatment. This is an absolute contraindication because fractional resurfacing depends on appropriate aftercare for predictable healing.

The assessment should include practical barriers, not only willingness. Limited support, difficulty understanding instructions, or inability to avoid excessive ultraviolet exposure may materially increase risk.

Unrealistic expectations

Unrealistic expectations or refusal to accept the expected recovery process are also treated as an absolute contraindication in the primary reference. The patient must understand that fractional resurfacing may require multiple sessions, has variable results, and can cause temporary or persistent adverse effects.

Treatment should be postponed when the patient expects guaranteed correction, immediate results, or no downtime. Consent cannot compensate for a fundamentally unsuitable treatment goal.

Relative Contraindications That Require Modification

Photosensitivity and collagen vascular disease

Photosensitivity associated with a collagen vascular disease or a light-sensitizing medication is a relative contraindication. The clinician must identify the cause, determine whether the condition is active, and evaluate whether the planned wavelength and energy are appropriate.

Active collagen vascular disease may warrant specialist input or deferral. Photosensitizing medications require a medication-specific risk assessment rather than automatic discontinuation.

Pregnancy and breastfeeding

Pregnancy or breastfeeding requires an individualized risk-benefit assessment and consultation with the patient’s obstetrician or other appropriate physician. The procedure is commonly deferred when there is no compelling medical need because elective resurfacing provides limited benefit relative to an avoidable exposure.

This status should be documented before treatment, particularly when topical anesthetics, antivirals, antibiotics, or other peri-procedural medications may be used.

Recent tissue-traumatizing procedures

Prior therapeutic radiation, deep chemical peeling, or dermabrasion within approximately three to twelve months is a relative contraindication. These procedures may have altered the skin’s appendages and healing capacity.

If treatment is considered, the clinician should confirm adequate recovery and use conservative energy and density settings. Previously irradiated or extensively damaged skin may require deferral or specialist evaluation.

Keloid or hypertrophic scar history

A history of keloid or hypertrophic scarring increases the risk of an abnormal scar response. It is generally a relative contraindication for fractional treatment, although some protocols may classify active or particularly severe keloid disease more strictly.

Risk reduction may include conservative parameters, careful counseling, and a small test area when clinically appropriate. The decision should account for the scar history, treatment location, and planned tissue injury.

Pigmentary risk and inflammatory skin disease

Darker Fitzpatrick skin types, prior post-inflammatory hyperpigmentation, vitiligo, psoriasis, and other disorders prone to Koebnerization require careful evaluation. These factors do not automatically prohibit fractional resurfacing, but they increase the importance of conservative settings and realistic counseling.

Active inflammatory disease in the treatment area generally warrants postponement. A history of pigmentary complications should influence device selection, energy, density, and follow-up planning.

Impaired healing and immunosuppression

Diabetes, impaired microvascular healing, active immunosuppression, systemic vasculitis, smoking, and other factors that compromise repair should be assessed before treatment. These are relative concerns unless the underlying condition is uncontrolled or the clinician determines that healing risk is unacceptable.

The screening process should review disease control, relevant medications, prior wound-healing problems, and the planned depth of injury. Deeper ablative treatments carry greater healing and bleeding concerns than superficial non-ablative procedures.

High ultraviolet exposure

Patients who cannot avoid substantial sun exposure before or after treatment have increased risk of dyschromia and prolonged inflammation. This is especially important for patients with darker skin phototypes or a history of post-inflammatory pigment changes.

Treatment should be delayed when adequate photoprotection is not realistic. Inability or refusal to follow required sun protection may become an absolute contraindication under the practice’s protocol.

Why Device Type and Treatment Depth Matter

Ablative versus non-ablative fractional treatment

Ablative fractional lasers intentionally remove microscopic columns of epidermis and dermis, creating a wound-healing requirement. Non-ablative fractional devices heat tissue without removing the same amount of surface tissue, but they still carry risks related to inflammation, pigment alteration, and photosensitivity.

Therefore, a contraindication list for deep ablative resurfacing should not automatically be transferred to every non-ablative treatment. The clinician must match the screening decision to the actual device and settings.

Fractional versus full-field resurfacing

Fractional treatment preserves untreated skin between treatment columns, which generally supports faster healing than full-field resurfacing. It does not eliminate the risks associated with infection, retinoid exposure, poor aftercare, scarring, or pigmentary complications.

Some supplementary sources describe longer retinoid deferral periods and stricter restrictions for deep full-field treatment. Those precautions may be relevant to the procedure being planned, but they should not be presented as universal rules for every fractional procedure.

Treatment depth and energy

Greater treatment depth and energy increase tissue injury and can increase bleeding, delayed healing, and infection risk. The screening assessment should therefore be completed alongside a review of the intended depth, density, pulse settings, treatment area, and whether the procedure is ablative.

A patient may be an acceptable candidate for conservative fractional treatment but an unsuitable candidate for aggressive or deep resurfacing. The correct decision is often to change the protocol rather than to treat every candidate identically.

Understanding the Trade-offs

Overly broad “absolute” lists

Conditions such as darker skin type, a remote history of keloids, diabetes, smoking, or prior herpes simplex infection are often better treated as risk modifiers than as universal absolute contraindications. Automatically excluding every patient with one of these features can deny appropriate treatment, while ignoring them can expose patients to preventable harm.

The key question is whether the risk can be reduced through disease control, prophylaxis, conservative settings, a test patch, or specialist consultation.

Conflicting retinoid intervals

References differ on whether systemic isotretinoin requires a six-month, twelve-month, or longer interval. This variation reflects differences in procedure depth, older concerns about wound healing, evolving evidence, and device-specific protocols.

Clinicians should document the medication, discontinuation date, planned procedure, and rationale for the deferral interval. The device manufacturer’s instructions and applicable professional or institutional guidance should take priority.

Treating an active skin disorder

Active acne, psoriasis, vitiligo, dermatitis, or another inflammatory condition may increase complications even when it is not listed as an absolute contraindication for every device. Treating through active disease can worsen inflammation or trigger pigmentary or Koebnerization responses.

The safer approach is usually to stabilize the condition first and then reassess candidacy.

Failing to assess the whole patient

Screening only the treatment area is insufficient. The clinician must review medications, pregnancy or breastfeeding status, immune function, wound-healing history, scarring tendency, sun exposure, expectations, and aftercare capacity.

A technically appropriate laser procedure can still produce a poor outcome when the patient selection or postoperative plan is inadequate.

How to Apply This to Clinical Screening

A practical screening decision should combine the patient’s risk factors with the intended device, treatment depth, and ability to complete aftercare.

If your primary focus is preventing acute complications: Defer treatment for active treatment-area infection, current or recent systemic retinoid exposure under the applicable protocol, inability to complete wound care, or unrealistic expectations.
If your primary focus is selecting appropriate treatment parameters: Evaluate photosensitivity, pregnancy or breastfeeding, prior radiation or deep resurfacing, impaired healing, immunosuppression, scarring history, and inflammatory skin disease before choosing energy and density.
If your primary focus is reducing pigmentary complications: Assess skin phototype, prior post-inflammatory hyperpigmentation, current ultraviolet exposure, and the patient’s ability to maintain strict photoprotection.
If your primary focus is treating a patient with a relative contraindication: Stabilize active disease, obtain relevant specialist input, consider antiviral prophylaxis when indicated, and use conservative treatment or a test patch where appropriate.

Safe fractional laser resurfacing begins with matching the patient, the device, and the treatment intensity before the first pulse is delivered.

Summary Table:

Contraindication	Type	Rationale
Active infection in treatment area	Absolute	Worsens infection, delays healing, increases scarring risk until resolved.
Current/recent oral retinoid therapy	Absolute	Impairs re-epithelialization; defer per protocol (often ≥6 months).
Inability to complete wound care	Absolute	Requires reliable aftercare to prevent complications.
Unrealistic expectations	Absolute	Consent cannot overcome unsuitable goals; multiple sessions may be needed.
Photosensitivity/collagen vascular disease	Relative	Assess cause and activity; modify treatment or defer if severe.
Pregnancy/breastfeeding	Relative	Individualized risk-benefit; usually deferred for elective procedures.
Recent tissue-traumatizing procedures	Relative	May alter healing; allow recovery (3-12 months) before treatment.
Keloid/hypertrophic scar history	Relative	Increased risk of abnormal scarring; use conservative settings and test areas.
Pigmentary risk & inflammatory skin disease	Relative	Higher risk of dyschromia; conservative settings essential.
Impaired healing/immunosuppression	Relative	Risk of poor healing; control underlying condition and consider depth.
High ultraviolet exposure	Relative	Increases dyschromia risk; require strict photoprotection or delay.

Ensure the safety and efficacy of your fractional laser procedures with professional-grade equipment from BELIS. Our advanced systems, including Diode, Alexandrite, CO2 Fractional, and more, are designed for precision and reliability in clinics and premium salons. For distributors, we offer OEM/ODM support, certifications, and supply reliability to boost your business. Contact us today to elevate your practice or distribution portfolio!